Bob Azopardi Patient Shares His Clinical Trial Experience Are patients that participate in clinical trials pioneers? Andrew Schorr, Patient Power Founder, interviewed Bob Azopardi, a 16-year CLL patient who participated in the Phase III arm of the venetoclax (Venclexta) clinical trial. Bob discusses his involvement on the trial including the many safety precautions in place for patients and the new quality of life he experiences. Get email alerts | Subscribe on YouTube | Like on Facebook | Follow on Twitter | Follow on Google+ |